$NVS
Novartis AG
XNYS•Health Care•Pharmaceutical Preparations
$143.57
▲+0.32%+$0.460
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is NVS up today? It is at $143.57 (+0.32%), and our scanner flagged it 24 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NVS spikes, and full due diligence on NVS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NVS 24 times in the last 30 days. Create a free account to track $NVS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on NVS from our scanner (live price and day move above). A recent catalyst in the news: “NVS Wins FDA Nod for Label Expansion of Immunology Drug Rhapsido.” Early read: bullish.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →A share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on NVS from our scanner (live price and day move above). A recent catalyst in the news: “NVS Wins FDA Nod for Label Expansion of Immunology Drug Rhapsido.” Early read: bullish.
NVS last traded at $143.57, up 0.32% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Novartis AG (NVS) is next expected to report earnings on Tuesday, October 27, 2026 (before open), about 19 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. NVS currently has a dividend yield of about 3.31% ($4.74 per share per year). Dividend figures can change; this is not investment advice.
The NVS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NVS 24 times in the last 30 days.
NVS (Novartis AG) trades on XNYS, with a market cap of about $291.20B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NVS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NVS discussion
Sign in to ask a question or join the discussion.